Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1  Year: An Open-Label, Non-Randomized, Controlled Study

ConclusionsThese results demonstrate that a novel metabolic and continuous remote care model can support adults with T2D to safely improve HbA1c, weight, and other biomarkers while reducing diabetes medication use.ClinicalTrials.gov IdentifierNCT02519309.FundingVirta Health Corp.

Source: Diabetes Therapy - February 7, 2018 Category: Endocrinology Source Type: research